Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells

Blood

Volumn 105, Issue 4, 2005, Pages 1669-1677

  Lal, Lakhvir ^b   Li, Yongzhong ^b   Smith, Jessica ^b   Sassano, Antonella ^b   Uddin, Shahab ^b   Parmar, Simrit ^b   Tallman, Martin S ^b   Minucci, Saverio ^b   Hay, Nissim ^b   Platanias, Leonidas C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RETINOIC ACID; RIBOSOME PROTEIN; S6 KINASE;

5' UNTRANSLATED REGION; ARTICLE; BLAST CELL; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PHOSPHORYLATION; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSLATION INITIATION;

EID: 13544274110     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2078     Document Type: Article

References (79)

1. Castaigne S, Chomlenne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia, I: clinical results. Blood. 1990;76:1704-1709.
2. Huang M, Ye Y, Chen S, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72:567-572.
3. Grignani F, Fagioli M, Alcalay M, et al. Acute promyelocytic leukemia: from genetics to treatment. Blood. 1994;83:10-25.
4. Melnick A, Licht JD. Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93:3167-3215.
5. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood. 2002;99:759-767.
6. Lutz PG, Moog-Lutz C, Cayre YE. Signaling revisited in acute promyelocytic leukemia. Leukemia. 2002;16:1933-1999.
7. Pitha-Rowe I, Petty WJ, Kitareewan S, Dmitrovsky E. Retinoid target genes in acute promyelocytic leukemia. Leukemia. 2003;17:1723-1730.
8. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood. 2002;100:4298-4302.
9. Tallman MS. Differentiating therapy in acute myeloid leukemia. Leukemia. 1996;10:1262-1268.
10. Ohno R, Asou N, Ohnishi K. Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate. Leukemia. 2003;17:1454-1463.
11. Tallman MS, Nabhan C. Management of acute promyelocytic leukemia. Curr Oncol Rep. 2002;4:381-389.
12. Agadir A, Chen G, Bost F, Li Y, Mercola D, Zhang X. Differential effect of retinoic acid on growth regulation by phorbol ester in human cancer cell lines. J Biol Chem. 1999;274:29779-29785.
13. Nicke B, Kaiser A, Wiedenmann B, Riecken EO, Rosewicz S. Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells. Biochem Biophys Res Commun. 1999;261:572-577.
14. Brodowicz T, Wiltschke C, Kandioler-Eckersberger D, et al. Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids. Br J Cancer. 1999;80:1350-1358.
15. Chen YH, Lavelle D, DeSimone J, Uddin S, Platanias LC, Hankewych M. Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1). Blood. 1999;94:251-259.
16. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999;59:2477-2483.
17. Nagy L, Thomazy VA, Heyman RA, Davies PJ. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ. 1998;5:11-19.
18. Szondy Z, Reichert U, Fesus L. Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors. Cell Death Differ. 1998;5:4-10.
19. Hsu SL, Chen MC, Chou YH, Hwang GY, Yin SC. Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp Cell Res. 1999;248:87-96.
20. Chambon P. The retinoid signaling pathway: molecular and genetic analyses. Semin Cell Biol. 1994;5:115-125.
21. Kastner P, Mark M, Chambon P. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell. 1995;83:859-869.
22. Wei LN. Retinoid receptors and their coregulators. Annu Rev Pharmacol Toxicol. 2003;43:47-72.
23. Kambhampati S, Verma A, Li Y, Parmar S, Sassano A, Platanias LC. Signaling pathways activated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Leuk Lymphoma. 2004;45:2175-2185.
24. Katagiri K, Yokoyama KK, Yamamoto T, Omura S, Irie S, Katagiri T. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J Biol Chem. 1996;271:11557-11562.
25. Alsayed Y, Modi S, Uddin S, et al. All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells. Exp Hematol. 2000;28:826-832.
26. Chen JY, Penco S, Ostrowski J, et al. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 1995;14:1187-1197.
27. Kamei Y, Xu L, Heinzel T, et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996;85:403-414.
28. Nagy L, Kao H-Y, Chakravarti D, et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell. 1997;89:373-380.
29. Han GR, Dohi DF, Lee HY, et al. All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. J Biol Chem. 1997;272:13711-13716.
30. Dimberg A, Karlberg I, Nilsson K, Oberg F. Ser727/Tyr701-phosphorylated Stal1 is required for the regulation of c-Myc, cyclins, and p27Kip1 associated with ATRA-induced G0/G1 arrest of U-937 cells. Blood. 2003;102:254-261.
31. Dimberg A, Nilsson K, Oberg F. Phosphorylation-deficient Stal1 inhibits retinoic acid-induced differentiation and cell cycle arrest in U-937 monoblasts. Blood. 2000;96:2870-2878.
32. Ferrari S, Thomas G. S6 phosphorylation and the p70s6k/p85s6k. Crit Rev Biochem Mol Biol. 1994;29:385-413.
33. Chou MM, Blenis J. The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signaling. Curr Opin Cell Biol. 1995;7:806-814.
34. Grammer TC, Cheatham L, Chou MM, Blenis J. The p70S6K signalling pathway: a novel signalling system involved in growth regulation. Cancer Surv. 1996;27:271-292.
35. Belham C, Wu S, Avruch J. Intracellular signalling: PDK1 - a kinase at the hub of things. Curr Biol. 1999;9:93-96.
36. Dufner A, Thomas G. Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res. 1999;253:100-109.
37. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 1992;69:1227-1236.
38. Kuo CJ, Chung J, Fiorentino DF, Flanagan WM, Blenis J, Crabtree GR. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 1992;358:70-73.
39. Jefferies HB, Fumagali S, Dennis PB, Reinhard C, Pearson RB, Thomas G. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k. EMBO J. 1997;16:3693-3704.
40. Volarevic S, Stewart MJ, Ledermann B, et al. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science. 2000;288:2045-2047.
41. Petritsch C, Beug H, Balmain A, Oft M. TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev. 2000;14:3093-3101.
42. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA. 2001;98:9666-9670.
43. Lekmine F, Uddin S, Sassano A, et al. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem. 2003;278:27772-27780.
44. Lekmine F, Sassano A, Uddin S, et al. Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp Cell Res. 2004;295:173-182.
45. Alsayed Y, Uddin S, Mahmud N, et al. Activation of Rad and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem. 2001;272:4012-4019.
46. Fanelli M, Minucci S, Gelmetti V, Nervi C, Cambacorti-Passerini C, Pelicci G. Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance. Blood. 1999;93:1477-1481.
47. Yetter A, Uddin S, Krolewski JJ, Jiao H, Yi T, Platanias LC. Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J Biol Chem. 1995;270:18179-18182.
48. Uddin S, Sassano A, Deb DK, et al. Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stal1 on serine 727. J Biol Chem. 2002;277:14408-14416.
49. Cichy SB, Uddin S, Danilkovich A, Quo S, Klippel A, Unterman TG. Protein kinase B/Akt mediates effects of insulin on hepatic insulin-like growth factor-binding protein-1 gene expression through a conserved insulin response sequence. J Biol Chem. 1998;273:6482-6487.
50. Kambhampati S, Li Y, Verma A, et al. Activation of protein kinase C delta by all-trans-retinoic acid. J Biol Chem. 2003;278:32544-32551.
51. Minnucci S, Zand DJ, Dey A, et al. Dominant negative retinoid X receptor beta inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells. Mol Cell Biol. 1994;14:360-372.
52. Guilbaud NF, Gas N, Dupont MA, Valette A. Effects of differentiation- inducing agents on maturation of human MCF-7 breast cancer cells. J Cell Physiol. 1990;145:162-172.
53. del Rincon SV, Rousseau C, Samanta R, Miller WH Jr. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI3-kinase/AKT pathway. Oncogene. 2003;22:3353-3360.
54. Kristof AS, Marks-Konczalik J, Billings E, Moss J. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. J Biol Chem. 2003;278:33637-33644.
55. Brunn GJ, Hudson CC, Sekulic A, et al. Phosphorylation of the translational repressor PHAS-1 by the mammalian target of rapamycin. Science. 1997;277:99-101.
56. Gingras A-C, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 1998;12:502-513.
57. Peterson RT, Schreiber SL. Translation control: connecting mitogens and the ribosome. Curr Biol. 1998;8:R248-250.
58. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-839.
59. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell. 1995;83:841-850.
60. Lin RJ, Sternsdorf T, Tini M, Evans RM. Transcriptional regulation in acute promyelocytic leukemia. Oncogene. 2001;20:7204-7215.
61. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J. 1998;332:281-292.
62. Kolla V, Lindner DJ, Weihua X, Borden EC, Kalvakolanu V. Modulation of interferon (IFN)-inducible gene expression by retinoic acid: up-regulation of STAT1 protein in IFN-unresponsive cells. J Biol Chem. 1996;271:10508-10514.
63. Kolla V, Weihua X, Kalvakolanu DV. Modulation of interferon action by retinoids: induction of murine STAT1 gene expression by retinoic acid. J Biol Chem. 1997;272:9742-9748.
64. Platanias LC, Fish EN. Signaling pathways activated by interferons. Exp Hematol. 1999;27:1583-1592.
65. Platanias LC. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther. 2003;98:129-142.
66. Grignani F, De Matteis S, Nervi C, et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature. 1998;391:1815-1828.
67. Lin RJ, Nagy L, Inoue S, Shao W, Miller WH Jr, Evans RM. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature. 1998;391:811-814.
68. Uddin S, Yenush L, Sun X, Sweet ME, White MF, Platanias LC. Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J Biol Chem. 1995;270:15938-15941.
69. Platanias LC, Uddin S, Yetter A, Sun X, White MF. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J Biol Chem. 1996;271:278-282.
70. Uddin S, Fish EN, Sher D, Gardziola C, White MF, Platanias LC. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. J Immunol. 1997;158:2390-2397.
71. Lopez-Carballo G, Moreno L, Masia S, Perez P, Barettino D. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem. 2002;277:25297-25304.
72. Carter CA. Retinoic acid signaling through PI 3-kinase induces differentiation of human endometrial adenocarcinoma cells. Exp Mol Pathol. 2003;75:34-44.
73. Bertagnolo V, Neri LM, Marchisio M, Mischiati C, Capitani S. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res. 1999;59:542-546.
74. Antonyak MA, Boehm JE, Cerione RA. Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase. J Biol Chem. 2002;277:14712-14716.
75. Antonyak MA, Singh US, Lee DA, et al. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis. J Biol Chem. 2001;276:33582-33587.
76. Grolleau A, Sonenberg N, Wietzerbin J, Berette L. Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation. J Immunol. 1999;162:3491-3497.
77. Kumar V, Pandey P, Sabatini D, et al. Functional interaction between RAFT1/FRAP/mTOR and protein kinase c delta in the regulation of cap-dependent initiation of translation. EMBO J. 2000;19:1087-1097.
78. Garber K. Rapamycin's resurrection: a new way to target the cancer cell cycle. J Natl Cancer Inst. 2001;93:1517-1519.
79. Elit L. CCI-779 Wyeth. Curr Opin Investig Drugs. 2002;3:1249-1253.